Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price80.70 EUR
Fair value56.82Our model only; no analyst estimate to cross-check.
Ethical score85.9/100
Value readOvervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-01Read Accumulation85.43-5.5% to today Markdown gives way to Accumulation after a 7% rise in 7 days
2026-10-25Read Markdown80.17+0.7% to today Markup gives way to Markdown
2026-10-18Read Markup80.17+0.7% to today ✓Distribution gives way to Markup first Markup read since October
2026-10-11Read Distribution78.56+2.7% to today Markup gives way to Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
TotalEnergies SE holds its Markup at $80.70. The statistical read favours the sellers, held for 117 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 117 days
Price at the screen
$80.70
Valuation
13.66 trailing · 9.58 forward price to earnings
Values screen
PASS· score 85.9
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.64%
Below 33%
Interest-bearing debt is just 20.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
8.30%
Below 33%
Cash held in interest-bearing accounts and securities is 8.3% of assets, under the one-third limit.
Pass
Receivables
6.38%
Below 49%
Money owed to the company is 6.4% of assets, under the 49% limit.
Pass
Revenue purity
0.62%
Below 5%
Only 0.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
TotalEnergies SE clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 21%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TTE.PA's ethical verdict changes
Today TTE.PA passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our model only; no analyst estimate to cross-check.
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our 56.82 EUR fair value estimate, 3.40% revenue growth.
Fair value range in EUR, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 42.0% above the base estimate.
Where our models see it going: fair-value estimate 56.82 EUR, with a range of 51.97 EUR to 86.61 EUR, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it gives us pause
At 9.6x forward earnings, the price already runs ahead of the business. It trades 42% above our 56.82 EUR fair value, so you would be buying at a premium, not a discount.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TTE.PA trades on EURONEXT PARIS. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
2026-10-25Markdown · changed$80.17+0.0%Entry 15
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
2026-10-18Markup · changed$80.17+2.0%Entry 14
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
2026-10-02Markup$78.56+1.0%Entry 12
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
2026-08-24Markup$77.80+0.0%Entry 11
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85.
2026-07-23Markup$77.80+0.0%Entry 10
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-22Markup$77.80+0.0%Entry 9
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-21Markup$77.80+0.0%Entry 8
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-20Markup$77.80+0.0%Entry 7
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 53%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (21 analysts) rates it buy, with a mean price target of $85. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.